These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34068110)

  • 1. Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment.
    Zając A; Sumorek-Wiadro J; Langner E; Wertel I; Maciejczyk A; Pawlikowska-Pawlęga B; Pawelec J; Wasiak M; Hułas-Stasiak M; Bądziul D; Rzeski W; Reichert M; Jakubowicz-Gil J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide and sorafenib as programmed cell death inducers of human glioma cells.
    Jakubowicz-Gil J; Bądziul D; Langner E; Wertel I; Zając A; Rzeski W
    Pharmacol Rep; 2017 Aug; 69(4):779-787. PubMed ID: 28587939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment.
    Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):580-9. PubMed ID: 24126416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway.
    Chen L; Han L; Shi Z; Zhang K; Liu Y; Zheng Y; Jiang T; Pu P; Jiang C; Kang C
    Mol Med Rep; 2012 Feb; 5(2):575-9. PubMed ID: 22086271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumarins modulate the anti-glioma properties of temozolomide.
    Sumorek-Wiadro J; Zając A; Bądziul D; Langner E; Skalicka-Woźniak K; Maciejczyk A; Wertel I; Rzeski W; Jakubowicz-Gil J
    Eur J Pharmacol; 2020 Aug; 881():173207. PubMed ID: 32446712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro.
    Sumorek-Wiadro J; Zając A; Skalicka-Woźniak K; Rzeski W; Jakubowicz-Gil J
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death.
    A Z; J SW; A M; E L; I W; W R; J JG
    Cell Tissue Res; 2021 Oct; 386(1):17-28. PubMed ID: 34236519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiglioma Potential of Coumarins Combined with Sorafenib.
    Sumorek-Wiadro J; Zając A; Langner E; Skalicka-Woźniak K; Maciejczyk A; Rzeski W; Jakubowicz-Gil J
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment.
    Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
    Tumour Biol; 2013 Aug; 34(4):2367-78. PubMed ID: 23580181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
    J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
    Shi L; Fei X; Wang Z; You Y
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling.
    Oppermann H; Faust H; Yamanishi U; Meixensberger J; Gaunitz F
    PLoS One; 2019; 14(6):e0218972. PubMed ID: 31247000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
    J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway.
    Zhang S; Lu Y; Li H; Ji Y; Fang F; Tang H; Qiu P
    Biosci Trends; 2020 May; 14(2):123-133. PubMed ID: 32173672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
    Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
    Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma.
    Shang C; Tang W; Pan C; Hu X; Hong Y
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):671-678. PubMed ID: 29397407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation.
    Imai Y; Yoshimori M; Fukuda K; Yamagishi H; Ueda Y
    Oncol Rep; 2012 Jun; 27(6):1703-9. PubMed ID: 22426819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.